Ignite Creation Date:
2025-12-25 @ 1:19 AM
Ignite Modification Date:
2025-12-25 @ 11:27 PM
Study NCT ID:
NCT02163993
Status:
COMPLETED
Last Update Posted:
2018-11-23
First Post:
2014-06-12
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
A Study of Galcanezumab (LY2951742) in Participants With Migraine Headache
Sponsor:
Eli Lilly and Company
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-07-07
Start Date Type:
ACTUAL
Primary Completion Date:
2015-08-19
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-02-12
Completion Date Type:
ACTUAL
First Submit Date:
2014-06-12
First Submit QC Date:
None
Study First Post Date:
2014-06-16
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-10-08
Results First Submit QC Date:
None
Results First Post Date:
2018-11-23
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2016-08-16
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2018-11-20
Last Update Post Date:
2018-11-23
Last Update Post Date Type:
ACTUAL